Siegfried EC, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, Co DO, Cordoro KM, Curran ML, Dalrymple AM, Flohr C, Gordon KB, Hanna D, Irvine AD, Kim S, Kirkorian AY, Lara-Corrales I, Lindstrom J, Paller AS, Reyes M, Begolka WS, Tom WL, Van Voorhees AS, Vleugels RA, Lee LW, Davies OMT, Brandling-Bennett HA PMID: 37316462
Eickstaedt J, Paller AS, Lund E, Murphrey M, Brandling-Bennett H, Maurano M, Fernandez Faith E, Holland KE, Ibler E, Liang MG, Todd PS, Siegfried E, Igelman S, Cordoro KM, Tollefson MM PMID: 37043214
Pelet Del Toro N, Yahia R, Feldman SR, Van Voorhees A, Green L, Schwartzman S, Siegel E, Cordoro KM, Desai SR, Kircik L, Liao W, Hawkes JE, Weinberg J, Koo J, Wallace EB, Howard LM, Armstrong A, Han G PMID: 37274387
García-Romero MT, Tollefson M, Pope E, Brandling-Bennett HA, Paller AS, Keimig E, Arkin L, Wanat KA, Humphrey SR, Werth VP, Oza V, Jacobe H, Fett N, Cordoro KM, Medina-Vera I, Chiu YE PMID: 36753150

846 A new case series of olmsted syndrome subjects confirms EGFR activation and long term efficacity of oral erlotinib with acceptable tolerance.

J. Basset, Y. Diab, F. Santiago, L. Azulay, K. Cordoro, A. Zhang, F. Watanabe, A. Kirkorian, F. Frascari, D. Siegel, E. Bourrat, R. Howard, A. Hovnanian PMID:
Lloyd-McLennan AM, Shimano KA, Dorsey M, Cordoro KM PMID: 35773537

Pediatric Dermatology Part II.

Kelly M. Cordoro PMID: